Areas of Focus
- Active ingredients of Traditional Chinese Medicine and natural medicine
- Clinical metabolism pharmacology
- Pharmacoeconomics
Work Experience
- 1988-1994 Pharmacist, First Affiliated Hospital of Hubei Medical University
- 1994-1999 Chief Pharmacist, First Affiliated Hospital of Hubei Medical University
- 1999-2001 Deputy Director and Associate Professor, Department of Pharmacy, Renmin Hospital of Wuhan University
- 2001-2015 Deputy Director of Clinical Pharmacy Research Lab, Renmin Hospital of Wuhan University (Promoted to Chief Pharmacist in 2004 and Professor in 2008)
- 2015-2020 Deputy Director of Pharmacy Department and Clinical Pharmacy Research Lab, Renmin Hospital of Wuhan University (Promoted to First-Level Chief Pharmacist in 2020)
- 2021-present Director of Pharmacy Department, Chief of Pharmacy, Director of Pharmacy at Shouyi Campus, Deputy Director of Clinical Pharmacy Research Lab, Renmin Hospital of Wuhan University
Academic Background & Achievements
- 1984-1988 Bachelor of Pharmacy, Hubei University of Chinese Medicine
- 1996-1999 Master of Medical Science in Pharmacology, Wuhan University Medical School (formerly Hubei Medical University)
- 2003-2007 Doctor of Science in Organic Chemistry, Wuhan University
- Short-term training at Johns Hopkins University School of Medicine, USA, December 2016
- Over 10 national and provincial level projects undertaken
- 6 National Natural Science Funds approved
- 3 invention patents granted
Publications
- Recent Advances and Perspectives on the Health Benefits of Urolithin B, A Bioactive Natural Product Derived From Ellagitannins, Zhou, B.H*., Chen, P., Guo, Z.I., Chen, F.C., Wu, Y., 2022
- Serum Metabolomics Analysis of the Anti-Inflammatory Effects of Gallic Acid on Rats With Acute Inflammation, Zhou, B.H*., Wu, Y., Li, K.Y., Zeng, M.L., Qiao, B.Y., 2022
- Urolithin A alleviates acute kidney injury induced by renal ischemia reperfusion through the p62-Keap1-Nrf2 signaling pathway, Zhou, B.H*., Zhang, Y., Liu, M.M., Zhang, Y.Y., Tian, M., Chen, P., Lan, Y., 2022
- The Gut Microbiota Metabolite Urolithin B Improves Cognitive Deficits by Inhibiting Cyt C-Mediated Apoptosis and Promoting the Survival of Neurons Through the PI3K Pathway in Aging Mice, Zhou, B.H*., Chen, P., Chen, F.C., Lei, J.X., Wang, G.H., 2021
- Gut microbial metabolite urolithin b attenuates intestinal immunity function in vivo in aging mice and in vitro in ht29 cells by regulating oxidative stress and inflammatory signalling, Zhou, B.H*., Chen, P., Chen, F., Lei, J.X., 2021
- Oral absorption mechanism of the polysaccharides from Gastrodia elata Blume base on fluorescence labeling, Zhou, B.H*., Zhang, B.Y., Liu, M.M., Liu, G., Li, D., 2021
- Urolithin A attenuates renal fibrosis by inhibiting TGF-beta 1/Smad and MAPK signaling pathways, Zhou, B.H*., Cheng, Z.Z., Tu, J.J., Zhang, H.P., Zhang, Y., 2021
- Effect of punicalagin on multiple targets in streptozotocin / high-fat diet induced diabetic mice, Zhou, B. H*., Jin, D., Zhang, B.Y., Li, Q. L., Tu, J. J., 2020
- Gallic acid inhibits bladder cancer T24 cell progression through mitochondrial dysfunction and pi3k/akt/nf-κb signaling suppression, Zhou, B.H*., Zeng, M.L, Su, Y., Li, K.Y, Jin, D., 2020
- Sacubitril-Valsartan Compared With En
Awards
- 2010 National Level Planning Textbook 'Natural Medicine Chemistry' by Higher Education Press, Beijing, Editorial Board Member
- 2021 National Level Planning Textbook 'Pharmaceutical Care Practice' by China Medical Science and Technology Press, Beijing, Editorial Board Member
- 2021 'Hubei Authentic and Characteristic Medicinal Materials' by Hubei Science and Technology Press, Hubei, Editorial Board Member
- 2009 Higher Education Planning Textbook 'Chinese Medicine Pharmaceutical Technology and Design' by Chemical Industry Press, Beijing, Deputy Editor
- 2019 'Transdermal Administration of Chinese Medicine and Functional Cosmetics' by China Medical Publishing House, Beijing
- 2003 Synthesis of Lotusine Derivatives and Their Anti-Arrhythmic Effects Study, Hubei Provincial Science and Technology Department, Reached Domestic Leading Level
- 2010 Development and Clinical Application of Sugar-Free Shenning Granules, Hubei Provincial Science and Technology Department, Reached Domestic Leading Level
- 2015 HPLC Quantitative Detection and Stability in Pain Pumps of Butorphanol Postoperative Multimodal Analgesia Solution, Hubei Provincial Science and Technology Department, Reached Domestic Leading Level
- 1997 Chinese Medicine Freckle-Removing Beauty Cream for Pigmentary Skin Diseases Study and Clinical Research, Hubei Provincial Medical Science and Technology Progress Third Prize
- 2017 Construction and Clinical Application of a Safe and Rational Drug Use System for Postoperative Multimodal Analgesia, Hubei Provincial Science and Technology Progress Third Prize